Data Curation

GenomOncology's dedicated in-house curation team extracts data-driven insights from unstructured data. Our team of precision medicine experts specializes in clinical data abstraction and curation, enhancing access to concise structured data for scientific research, analysis, and institution-specific data strategies.

With a specific focus on clinical trials, FDA-approved and guideline-based therapies, private protocols, pathology reports, NGS reports, and institution-specific clinical protocols, GenomOncology's in-house curation team leverages our advanced NLP and quality assurance solution, igniteIQ, to streamline data extraction and analysis. By combining automated processes with manual review, we ensure efficient and accurate extraction of clinical data, facilitating the utilization of institution-specific or valuable data to enhance opportunities and outcomes.

Quality Control

To ensure the accuracy of extraction and curation, GenomOncology employs both automated and manual validation methods. Our in-house curation team utilizes streamlined technology and established rules and specifications to guarantee output accuracy. Additionally, we employ a quality control tool that presents a side-by-side view of imaged documents and discrete data elements, reducing extraction errors and ensuring the integrity of the overall extraction process.

Curated Content

All biomarker-based clinical trials and therapies are curated and accessible within our precision oncology solutions due to our in-house curation team, and partnerships with leading content institutions.

Data Set Annotations

Our team validates numerous data sets, such as ClinVar, COSMIC, and gnomAD, on a quarterly basis, ensuring the latest data sets are available within the precision oncology solutions.

Institution-Specific Content

Proprietary content and data specific to an institution can be added to GenomOncology’s precision oncology solution set, enabling the incorporation of licensed content or history assertions.